KR840004415A - 옥사졸 유도체의 제조방법 - Google Patents

옥사졸 유도체의 제조방법 Download PDF

Info

Publication number
KR840004415A
KR840004415A KR1019830001606A KR830001606A KR840004415A KR 840004415 A KR840004415 A KR 840004415A KR 1019830001606 A KR1019830001606 A KR 1019830001606A KR 830001606 A KR830001606 A KR 830001606A KR 840004415 A KR840004415 A KR 840004415A
Authority
KR
South Korea
Prior art keywords
defined above
formula
compound
salt
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019830001606A
Other languages
English (en)
Korean (ko)
Inventor
간지 메구로 (외 1)
Original Assignee
구라바야시 이꾸시로오
다께다 야꾸힝 고오교오 가부시시 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구라바야시 이꾸시로오, 다께다 야꾸힝 고오교오 가부시시 가이샤 filed Critical 구라바야시 이꾸시로오
Publication of KR840004415A publication Critical patent/KR840004415A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019830001606A 1982-04-19 1983-11-16 옥사졸 유도체의 제조방법 Withdrawn KR840004415A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP82-66124 1982-04-19
JP57066124A JPS58183676A (ja) 1982-04-19 1982-04-19 オキサゾ−ル誘導体

Publications (1)

Publication Number Publication Date
KR840004415A true KR840004415A (ko) 1984-10-15

Family

ID=13306807

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001606A Withdrawn KR840004415A (ko) 1982-04-19 1983-11-16 옥사졸 유도체의 제조방법

Country Status (14)

Country Link
US (1) US4596816A (https=)
EP (1) EP0092239A3 (https=)
JP (1) JPS58183676A (https=)
KR (1) KR840004415A (https=)
AU (1) AU1355283A (https=)
CA (1) CA1195985A (https=)
DK (1) DK172183A (https=)
ES (1) ES8603174A1 (https=)
FI (1) FI831253L (https=)
GR (1) GR79251B (https=)
HU (1) HU187002B (https=)
NO (1) NO831361L (https=)
PT (1) PT76563B (https=)
ZA (1) ZA832657B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
ZW19786A1 (en) * 1985-10-17 1988-05-18 Hoffmann La Roche Heterocyclic compounds
GB8531608D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Treatment
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0440183A1 (en) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Oxazole compounds, their production and use
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE227710T1 (de) * 1996-04-03 2002-11-15 Takeda Chemical Industries Ltd Oxazole derivate,ihre herstellung und verwendung
EP1077958A1 (en) * 1998-05-12 2001-02-28 American Home Products Corporation Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
US6699896B1 (en) 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
EP1077966B1 (en) * 1998-05-12 2002-11-20 Wyeth Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
CZ20032829A3 (cs) 2001-04-16 2005-03-16 Tanabe Seiyaku Co., Ltd. Heterocyklické sloučeniny

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (https=) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles

Also Published As

Publication number Publication date
AU1355283A (en) 1983-10-27
ZA832657B (en) 1984-01-25
FI831253A7 (fi) 1983-10-20
PT76563A (en) 1983-05-01
JPS58183676A (ja) 1983-10-26
PT76563B (en) 1986-05-07
ES521865A0 (es) 1985-05-16
FI831253A0 (fi) 1983-04-14
EP0092239A2 (en) 1983-10-26
NO831361L (no) 1983-10-20
CA1195985A (en) 1985-10-29
US4596816A (en) 1986-06-24
FI831253L (fi) 1983-10-20
DK172183D0 (da) 1983-04-19
ES8603174A1 (es) 1985-05-16
GR79251B (https=) 1984-10-22
HU187002B (en) 1985-10-28
DK172183A (da) 1983-10-20
EP0092239A3 (en) 1985-01-23

Similar Documents

Publication Publication Date Title
KR870004019A (ko) 퀴놀린 유도체의 제조방법
KR910021385A (ko) 할로게노알릴-아졸릴 유도체
KR840004415A (ko) 옥사졸 유도체의 제조방법
KR900016251A (ko) 신규 스테로이드 유도체
KR830006219A (ko) 아미노산 유도체의 제조방법
KR870010005A (ko) 퀴놀린 유도체 및 그의 에스테르 또는 염의 제조법
KR870007890A (ko) 1,2,5,6-테트라히드로피리딘-3-카르복시알데히드 옥심유도체의 제조방법
KR920701143A (ko) S-저급지방산 글루타티온 유도체
KR850001905A (ko) 벤조시클로 알칸 유도체의 제조방법
PT88529A (pt) Procede de synthese d'alpha amino acides n alkykes et de leurs esters application a la synthese de carboxylalkyl dipeptides
KR890006604A (ko) 사이클릭 안트라닐산 유도체 및 이의 제조방법
KR860006462A (ko) 1,8-나프틸리딘 유도체, 그 에스테르 또는 그 염의 제조방법
WO1993009111A3 (en) Novel methods for the preparation of glycerol carbonate esters
KR880701234A (ko) 신규 비페닐 유도체와 그의 제조 방법 및 용도
KR890006620A (ko) 퀴놀린 유도체 및 그의 제조법
KR840000521A (ko) 3-메틸플라본-8-카르복실산 에스테르류의 제조방법
KR850004959A (ko) 아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스 아미드 및 카보티오 아미드의 제조방법
KR840008151A (ko) 피라졸로 [1,5-a] 피리딘 유도체의 제조방법
KR850001898A (ko) 메티오닌 하이드록시 동족체 또는 유도체 및 그의 에스테르의 제조방법
ES8703401A1 (es) Procedimiento para la obtencion de esteres del acido 4-aci- loxi-3-oxo-butirico
ATE18208T1 (de) N-(4-hydroxyphenyl)essigsaeureamid-estern aus 5benzoyl-1-methylpyrrol-2-essigsaeure.
ES479712A1 (es) Procedimiento para la preparacion de n-bencilaminoacidos quecontienen azufre.
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
KR880006215A (ko) 티아졸 화합물의 제조방법
KR900009603A (ko) 광학 활성 2-옥소이미다졸리딘 유도체의 제조 방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1202 Submission of document of withdrawal before decision of registration

St.27 status event code: N-1-6-B10-B11-nap-PC1202

WITB Written withdrawal of application
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000